Reovirus as an oncolytic agent against experimental human malignant gliomas (Q43646730)

25 November 2017

Reovirus as an oncolytic agent against experimental human malignant gliomas (English)

1 reference

25 November 2017

1 reference

1 reference

Wilcox ME

1

1 reference

25 November 2017

Yang W

2

1 reference

25 November 2017

Senger D

3

1 reference

25 November 2017

Rewcastle NB

4

1 reference

25 November 2017

Morris DG

5

1 reference

25 November 2017

Brasher PM

6

1 reference

25 November 2017

Shi ZQ

7

1 reference

25 November 2017

Johnston RN

8

1 reference

25 November 2017

Nishikawa S

9

1 reference

25 November 2017

Lee PW

10

1 reference

25 November 2017

Forsyth PA

11

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Journal of the National Cancer Institute

25 November 2017

1 reference

25 November 2017

93

1 reference

25 November 2017

12

1 reference

25 November 2017

903-912

1 reference

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

25 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Combination gene therapy for liver metastasis of colon carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Intergeneric poliovirus recombinants for the treatment of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Protein sigma 1 is the reovirus cell attachment protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Gene transfer technologies for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Inflammatory thoughts about glioma gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.12.903

21 January 2018

Identifiers

DOI

10.1093/JNCI/93.12.903

1 reference

25 November 2017

1 reference